Author

Weijiao Zhang

University of OxfordORCID 0000-0001-9275-7817Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Adam C. WilkinsoniD· 1 shared Adam J. MeadiD· 1 shared Bethan PsailaiD· 1 shared Eleni LoukaiD· 1 shared James O. J. DaviesiD· 1 shared Joseph C. HamleyiD· 1 shared Lai Cheng· 1 shared Maria GrecoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam C. WilkinsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 19, 2025

Genome editing for treatment of JAK2 V617F-driven myeloproliferative neoplasms

Roman M. Doll, Yuqi Shen, Zoë C. Wong…·James O. J. Davies

This study uses CRISPR-Cas genome editing to selectively inactivate JAK2 V617F mutations in patient cells, showing that heterozygous cells are not oncogene addicted while homozygous cells are eradicated, suggesting genome editing as a potential treatment for MPNs.

1 citation

humangenetic perturbation / CRISPR

𝕏 PostBluesky